A GROUND-BREAKING vote by a committee of the Spanish Parliament has led to the creation of a working group to look into the benefits of medical cannabis.
One of its stated aims is to examine the legal basis and scientific evidence for the implementation of a medical cannabis programme.
To do this it will;
-Analyse the experiences of other governments that have regulated medical cannabis access schemes with the input of foreign government and other experts in the field.
-And, produce a report with proposals for the best practices into the control of medical cannabis in Spain.
The report will be completed and presented by the sub-committee within six months of the initiation of the project and appraised by the Health and Consumer Affairs Commission before being sent for further consideration to the Spanish Congress.
Yesterday’s vote was carried by 20 to 14 after being filed by the Grupo Parlamentario Vasco (Basque Parliamentary Group), with the support of several groups, including the Observatario España de Cannabis Medicinal (Spanish Medicinal Cannabis Observer).
Conor O’Brien, a senior analyst with Prohibition Partners, said: “The creation of the subcommittee represents an important first step in the liberalisation of medical cannabis by the Spanish government.
“This move could open up the path to medical cannabis access in Spain in the coming years. The country currently remains as the largest country in Europe without some form of medical cannabis access.”
In advance of the opening up of medical cannabis access, the Spanish government has allowed for the production and export of medical cannabis products, which have led to the creation of a relatively active market in the country.
Currently, 19 companies are approved to cultivate medical cannabis in the country, with a few companies manufacturing medical cannabis products at commercial scale. Amongst these are some international players, for example Linneo Health, which has exported to Germany in the past; Cafina, owned by Canopy Growth; and Medalchemy, a subsidiary of EMMAC, which was acquired by US giant Curaleaf for €235 million in March of this year.
The legality of personal cultivation and consumption of cannabis has led to the rise of cannabis social clubs in Spain.
According to the latest statistics, the prevalence of cannabis use in Spain sits at around 10% of the adult population, or just under 4 million adult users each year, many of whom are likely using it for medical purposes.
Prohibition Partners estimates that if Spain were to legalise medical cannabis treatment and implement a framework for prescription in 2022, we would expect to see over €60m in annual sales by 2025, with 1,700 kilograms plus of cannabis flower equivalents used to treat over 30,000 patients in that year alone.
While Spain was among the first countries in Europe to decriminalise the personal use of cannabis, regulations on medical cannabis are trailing behind much of western and central Europe.
This is despite the fact that over 90% of the public support the legalisation of medical cannabis in Spain according to a recent survey by the Center for Sociological Research.
@A copy of the official proposal is available here, in Spanish.
Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Oklahoma is already famous for the iconic Broadway Show, world-class tornadoes, and the basketball team that once had James Harden coming off the bench behind KD and Russell Westbrook. Now it has a new distinction: the most medical cannabis patients per capita of any state in the country. Oklahoma’s medical market has absolutely boomed in…
As Illinois begins to award much-delayed cannabis business licenses, the new business owners will face a long uphill climb. They’ll be pitting mom-and-pop startups against giant companies that have had a five-year head start to take control of the market. Entry-level entrepreneurs will have, in many cases, one dispensary to compete with companies that control…
by Nathalie Bougenies, Attorney at Harris Bricken On July 22, the Washington State Liquor and Cannabis Board (“LCB”) issued a notice of adoption of an interpretive statement (the “Notice”) in which the agency clarified authorized practices for marijuana processor licensees. The Notice stipulates that licensed marijuana processors cannot legally convert cannabidiol (“CBD”) into delta-9 THC…
CBE recently spoke with Sunderstorm co-founder and president Keith Cich about the company’s ongoing commitment to improve upon its already popular Kanha gummy, plans to expand production and distribution into more states, and the inevitable addition of new SKUs to its portfolio of products, which currently includes Wind vapes and Nano5 tinctures in addition to…